Straits Times Index
3,284.30 -8.83 (-0.27%) Nikkei
37,686.48 -773.60 (-2.01%) Hang Seng
17,281.54 +80.27 (+0.47%) FTSE 100
8,040.38 -4.43 (-0.06%) Bitcoin USD
64,183.36 -2,455.05 (-3.68%) CMC Crypto 200
1,390.42 -33.68 (-2.37%)
Galapagos NV (GLPG.AS)
| Previous close | 27.56 |
| Open | 27.56 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 27.10 - 27.76 |
| 52-week range | 26.86 - 41.92 |
| Volume | |
| Avg. volume | 81,163 |
| Market cap | 1.787B |
| Beta (5Y monthly) | 0.02 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.06 |
| Earnings date | 02 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 41.00 |
ZacksDown -9.97% in 4 Weeks, Here's Why You Should You Buy the Dip in Galapagos (GLPG)
The heavy selling pressure might have exhausted for Galapagos (GLPG) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
GlobeNewswireGalapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024
Two oral presentations and one poster on encore preliminary data from Phase 1/2 CD19 CAR-T studies in non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL) / Richter transformation (RT) Mechelen, Belgium; 4 April 2024, 22:01 CET – Galapagos NV (Euronext & NASDAQ: GLPG) today announced that four abstracts, including two oral presentations on encore preliminary clinical and translational data for its seven-day vein-to-vein CAR-T product candidates GLPG5101 and GLPG5201, will be present
ZacksAfter Plunging -7.94% in 4 Weeks, Here's Why the Trend Might Reverse for Galapagos (GLPG)
The heavy selling pressure might have exhausted for Galapagos (GLPG) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
